(Press-News.org) Physicians across the country have analyzed the emerging scientific data about the long-term effects of COVID-19, creating an initial knowledge base about the clinical experiences of so-called "long-haulers" - patients with COVID-19 who experience prolonged symptoms and/or the emergence of new ones well after the initial viral infection has resolved. A comprehensive review published today in Nature Medicine offers an initial glimpse of the multi-organ effects of long-term COVID-19 and suggests a framework for the care of COVID-19 long-haulers through dedicated, multidisciplinary clinics.
"It was important to respond to our patients' concerns and pay close attention to the symptoms they were experiencing beyond the acute phase of COVID-19," said Kartik Sehgal, MD, a lead author of the new study and a medical oncologist at Dana-Farber Cancer Institute and Brigham and Women's Hospital, and instructor in medicine at Harvard Medical School. "While our knowledge in this area is still evolving and will continue to evolve over the next few years, we have provided a comprehensive resource for physicians caring for patients who have recovered from acute COVID-19 and scientists currently investigating the potential prolonged effects of COVID-19."
Sehgal and his colleagues at hospitals affiliated with Harvard University and Columbia University worked at the frontlines of the pandemic last spring and have witnessed first-hand the myriad health effects that the responsible virus, known as SARS-CoV-2, can inflict. That includes the recognition that COVID-19 is not simply an illness of the lungs or respiratory tract but can also affect many other organ systems. Sehgal was among the co-authors of a study published last summer in Nature Medicine that summarized the vast constellation of multi-organ symptoms associated with the COVID-19.
As the pandemic wore on, the team heard from their own patients as well as patient advocacy groups about surprisingly persistent symptoms - complications that extended for weeks, even months, beyond the initial infection.
"COVID-19 is the first infectious disease that I've come across that has such an effect on a wide variety of organs. It's changed my clinical practice. No matter what the patient comes in for, I now ask if they ever had COVID-19. It changes the possible range of diagnoses," added Elaine Y. Wan, MD, the Esther Aboodi Assistant Professor of Medicine in Cardiology and Cardiac Electrophysiology at Columbia University Vagelos College of Physicians and Surgeons and senior author of the study.
These observations prompted the authors to undertake a comprehensive review of the published literature on long-term effects of COVID-19 so they could develop a better understanding of the condition themselves and share it with the physician and scientific community.
They found that the most common symptoms of long COVID include fatigue, shortness of breath, brain fog, loss of sense of smell or taste, anxiety, depression, and post-traumatic stress disorder (PTSD). Based on the limited number of studies published to date, at least one-third of patients who required hospitalization for COVID-19 have experienced one of these long-term side effects. While there is much more work yet to be done, this finding is consistent with what has been found in the few studies of survivors of the SARS epidemic in 2003 as well as the MERS outbreak in 2012, which involved viruses that are closely related to SARS-CoV-2.
"The medical needs of patients with COVID-19 don't stop at the time of hospital discharge and they also don't necessarily stop after three to four weeks, even for those who didn't require hospitalization," said Sehgal. "It is important for physicians to be aware of these possible symptoms and complications and to have resources available for early recognition to provide the best possible care."
Because the symptoms of long COVID are not typically restricted to just one organ system, the researchers stress the importance of multidisciplinary care, such as a dedicated COVID-19 clinic that includes specialists with expertise in diverse areas of clinical medicine. "It is important to not forget about the mental health effects of COVID-19 in these patients, while taking care of their physical symptoms," said Sehgal.
Some academic medical centers have already established such an effort. In response to the clinical need and the emerging research findings, the Brigham Lung Center has recently established a COVID Recovery Center to coordinate and deliver multi-disciplinary care for patients with long-term symptoms after infection.
Moving forward, Sehgal and his colleagues believe it will also be essential to develop mechanisms for appropriately sharing and pooling patient data across organizations and institutions, including from patient advocacy groups, which played a major role in highlighting the health struggles of long haulers.
"There are a lot of questions we'll need to answer," said Sehgal. "The only way we can do that quickly is by systematically collecting and harnessing all of the data that's out there."
INFORMATION:
The co-authors of the study are Ani Nalbandian, MD; Aakriti Gupta, MD, MS; Mahesh Madhavan, MD; Claire McGroder, MD; Jacob Stevens, MD; Joshua Cook, MD, PhD; Anna Nordvig, MD; Daniel Shalev, MD; Tejasav Sehrawat, MBBS; Neha Ahluwalia, MD; Behnood Bikdeli, MD; Donald Dietz, MD; Caroline Der-Nigoghossian, PharmD; Nadia Liyanage-Don, MD; Gregg Rosner, MD; Elana Bernstein, MD, MSc; Sumit Mohan, MD; Akinpelumi Beckley, MD, MBA; David Seres, MD, ScM, PNS; Toni Choueiri, MD; Nir Uriel, MD, MSc; John Ausiello, MD; Domenico Accili, MD; Daniel Freedberg, MD; Matthew Baldwin, MD, MS; Allan Schwartz, MD; Daniel Brodie, MD; Christine Kim Garcia, MD, PhD; Mitchell S.V. Elkind, MD, MS, MPhil; Jean M. Connors, MD; John Bilezikian, MD; Donald Landry, MD; and Elaine Wan, MD, FACC, FAHA, FHRS.
Funding for this work came from the following organizations and grants: National Institutes of Health (K23 DK111847, T32 HL007854, R01 HL152236, and R03HL146881), National Institute of Diabetes and Digestive and Kidney Diseases (R01-DK114893, R01-MD014161, U01-DK116066), National Institute of Neurological Disorders and Stroke (T32 NS007153-36), National Institute of Aging (P30 AG066462-01), Department of Defense (PR181960), the Esther Aboodi Endowed Professorship at Columbia University, the Foundation for Gender-Specific Medicine, Louis V. Gerstner, Jr. Scholars Program, and the Wu Family Research fund.
About Dana-Farber/Brigham and Women's Cancer Center
Dana-Farber/Brigham and Women's Cancer Center (DF/BWCC) brings together specialists from two world-class medical centers. Physicians from both hospitals bring deep experience in treating various cancers and the care teams include experts from a wide span of disciplines, such as medical and radiation oncologists, cancer surgeons and many others. DF/BWCC offers access to the latest treatments, many of which were pioneered at DF/BWCC, along with clinical trials for promising new therapies.
For more information visit: https://www.youhaveus.org
Oncotarget published "Predictors of immunotherapy benefit in Merkel cell carcinoma" which reported that the authors retrospectively analyzed electronic health records and next-generation sequencing data of 45 patients treated at our institution from 2013 to 2020 to understand clinical and genomic correlates of benefit from immunotherapy.
They reported that their cohort predominantly included individuals with stage III disease at primary disease diagnosis and individuals with stage IV disease at recurrent/metastatic disease diagnosis.
Less advanced stages at primary disease diagnosis and shorter disease-free interval between completion of initial treatment and recurrence were each associated with greater odds of response.
Single-nucleotide ...
Oncotarget published "Cytogenetic and molecular landscape and its potential clinical significance in Hispanic CMML patients from Puerto Rico" which reported that one hundred and eleven Hispanic CMML patients from Puerto Rico were diagnosed in our institute from 2009 to 2018. Karyotypes were available in one hundred and seven patients.
Compared to previously published data, Hispanic CMML patients in this study had significantly lower rates of overall cytogenetic abnormalities and trisomy 8.
Among one hundred and eleven Hispanic CMML patients, 40-gene myeloid molecular profile tests were performed in fifty-six CMML patients.
Previous studies indicated that mutated ASXL1, DNMT3A, NRAS, RUNX1, and SETBP1 may associate with an unfavorable prognosis ...
Oncotarget published "Ibuprofen disrupts a WNK1/GSK3β/SRPK1 protein complex required for expression of tumor-related splicing variant RAC1B in colorectal cells" which reported that although the molecular mechanism behind the antitumor properties of NSAIDs has been largely attributed to inhibition of cyclooxygenases , several studies have shown that the chemopreventive properties of ibuprofen also involve multiple COX-independent effects.
One example is its ability to inhibit the alternative splicing event generating RAC1B, which is overexpressed in a specific subset ...
Aging-US published "Aging and rejuvenation - a modular epigenome model" which reported that the view of aging has evolved in parallel with the advances in biomedical sciences.
Long considered as an irreversible process where interventions were only aimed at slowing down its progression, breakthrough discoveries like animal cloning and cell reprogramming have deeply changed our understanding of postnatal development, giving rise to the emerging view that the epigenome is the driver of aging. The idea was significantly strengthened by the converging discovery that DNA methylation at specific CpG sites could be used as a highly accurate biomarker of age defined by an algorithm known as the Horvath clock (also published in Aging-US here).
It was at this point ...
Having the right tool for the job makes the job a lot easier, less expensive and faster. Chemical engineering researchers have now developed a virtual laboratory that can be used to determine the artificial intelligence (AI) tools best suited for addressing various chemical synthesis challenges in flow chemistry systems.
"Autonomous systems have tremendous potential for accelerating chemical R&D and manufacturing, but they are not in widespread use yet," says Milad Abolhasani, corresponding author of a paper on the work and an assistant professor of chemical engineering at North Carolina State University. "These systems face two kinds of ...
Scientists from MIPT and ITMO University and their colleagues have studied the formation and growth of crystals from simple organic molecules into large associations. These experiments will help create capsules for targeted drug delivery to specific tissues in the human body. The scientific paper was published in the journal Crystal Growth & Design.
Melamine cyanurate consists of melamine, colourless crystals, and cyanuric acid, whose molecules associate in a similar way to DNA formation. The various studies associated with it could be useful ...
COLUMBUS, Ohio - As psychedelics gain ground as a potential therapy for mental health disorders, there remains a pressing concern that patients in clinical trials may have adverse effects to the drugs.
New research identifies personality traits that have been associated with positive and negative experiences on psychedelics in previous studies, information that could help predict how future clinical trial participants will respond to the drugs.
The findings suggest that people more open to new experiences and willing to surrender to the unknown may be best positioned to have a positive experience on psychedelics, and individuals who tend to be preoccupied or apprehensive could be more likely to have a ...
ITHACA, N.Y. - As the COVID-19 pandemic took hold in 2020, the list of things people could not do grew increasingly long.
But while going to the office, attending live events and gathering with large groups of friends became difficult or impossible, other activities grew in popularity - including online learning.
Drawing on records from DataCamp, an online platform tailored toward programming skills, a research team at Cornell University and Arizona State University used U.S. states' staggered adoption of nonessential business closures (NBC) to estimate their effects on the demand for online learning. The gradual closure of businesses across the U.S. gave the researchers a way to make a case for the cause and effect of NBC on increased engagement with the DataCamp ...
Aging-US published "Impact of adiposity on muscle function and clinical events among elders with dynapenia, presarcopenia and sarcopenia: a community-based cross-sectional study" which reported that low muscle function determined unfavorable clinical outcome than low muscle mass; nevertheless, comparison of detrimental parameters among dynapenia, presarcopenia and sarcopenia was sparse.
The authors hypothesized that adiposity is implicated in low muscle function related adverse events.
Associations of different obesity parameters, metabolic syndrome and fall among the groups were analyzed.
Among 765 participants, ...
The COVID-19 and Cancer Consortium (CCC19) published new findings in the Annals of Oncology, showing heightened mortality and racial disparities for patients with cancer diagnosed with SARS-CoV-2 infection.
After reviewing detailed information from almost 5,000 patients with active or past cancer and laboratory-confirmed COVID-19 diagnosis, CCC19 study authors found associations among laboratory measures, clinical factors -- including older age, hematological malignancy and recent chemotherapy - and poor clinical outcomes. Of the patients in the study with COVID-19 ...
